Log in
Enquire now
Junevity

Junevity

Junevity develops medicines targeting transcription factors to reverse diseases of aging.

OverviewStructured DataIssuesContributors

Contents

junevity.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biotechnology
Biotechnology
Artificial Intelligence (AI)
Artificial Intelligence (AI)
Health technology
Health technology
Location
San Francisco, California, United
San Francisco, California, United
B2X
B2B
B2B
CEO
‌
John Hoekman
Founder
‌
John Hoekman
Number of Employees (Ranges)
1 – 10
Email Address
founders@junevity.com
Investors
Goldcrest Capital
Goldcrest Capital
‌
Godfrey Capital
Total Funding Amount (USD)
30,000,000
Latest Funding Round Date
December 3, 2025
Latest Funding Type
Seed
Seed

Other attributes

Latest Funding Round Amount (USD)
20,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Junevity

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us